News

Innovative Converged Devices (ICD) unveiled Vega, their first in a future line of Android products of low priced, full featured High Definition entertainment and information devices that feature 3G ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Background: Multiple clinical trials have shown that a properly functioning implantable cardioverter-defibrillator (ICD) is capable of interrupting sudden death caused by ventricular tachyarrhythmias.
Implantable cardioverter-defibrillator (ICD) generator replacement in Canadian patients with devices that were recalled was associated with an 8 percent rate of complications, according to a study in ...
Background: The number of implantable cardioverter defibrillator (ICD) replacements is increasing, which adds to patient risk and costs. Objectives: To understand the impact of increasing ICD ...
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Elderly patients diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators for primary prevention of sudden cardiac death live longer than those that do not. Further, ...
An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes in non-MRI-conditional implantable cardioverter defibrillators, data from a ...
CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a ...